icon-folder.gif   Conference Reports for NATAP  
 
  EASL - The International Liver Congress 2014
49th Annual Meeting of the European
Association for the Study of the Liver
London, United Kingdom  April 9-13
Back grey_arrow_rt.gif
 
 
 
SAPPHIRE-I: PHASE 3 PLACEBO-CONTROLLED STUDY OF INTERFERON-FREE, 12-WEEK REGIMEN OF ABT-450/r/ABT-267, ABT-333, AND RIBAVIRIN IN 631 TREATMENT-NAĻVE ADULTS WITH HEPATITIS C VIRUS GENOTYPE 1
 
 
  Reported by Jules Levin
EASL 2014 April 9-13 London, UK
 
Jordan J. Feld, Kris V. Kowdley, Eoin Coakley, Samuel Sigal, David Nelson, Darrell Crawford, Ola Weiland, Humberto Aguilar, Junyuan Julia Xiong, Barbara DaSilva-Tillmann, Lois Larsen, Thomas Podsadecki

EASL1.gif

EASL2.gif

EASL4.gif

EASL5.gif

EASL6.gif

EASL7.gif

EASL8.gif

EASL9.gif

EASL10.gif

EASL11.gif

EASL12.gif

EASL13.gif

EASL14.gif